Addus HomeCare Corporation

NASDAQ:ADUS

Medical - Care Facilities

Healthcare
$120.85 +0.31%

+$0.29 today

Market cap
$2.25B
Beta
0.90
P/E (TTM)
17.4
EPS (TTM)
$5.40
52W Low $87.95High $124.44

Volume 0.23M

Average 0.25M

ADUS EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Addus HomeCare CorporationNASDAQ: ADUS

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA grows, but more slowly than its trailing trend

Q2 FY2026 EBITDA of $43.63M rose 16.7% year over year, behind the +23.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 13.0% from the prior quarter. Over 3 fiscal years it compounded at +22.7% a year.

Context

  • EBITDA amounted to 10.8% of revenue in FY2025, up 0.3 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 9 analysts of $198.22M (+29.2%) for the fiscal year ending Dec 2026, a step up from the +27.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$43.63M+13.0% QoQ
Last fiscal yearDec 2025
$153.44M+27.2% YoY
LTMJun 2026
$167.37M+23.6% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.7%+28.3%+11.6 pp
1 year+27.2%+29.2%+2.0 pp
3-year CAGR+22.7%+13.5%-9.2 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
153.44M USD
Year-over-year change
+27.2%
4-year CAGR
+17.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How ADUS compares with its peers on the latest reported figures

  • ADUS's LTM Jun 2026 EBITDA of $167.37M is the 6th highest of the 7 companies compared; the peer median is $389.68M.
  • Its year-over-year change of +23.6% is the 2nd highest of 7, against a peer median of +16.5%.
  • EBITDA amounts to 11.3% of revenue for ADUS, versus a peer median of 13.1%.
ADUS Competitors Peer median
EBITDA for ADUS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EHCEncompass Health CorporationLTM Jun 2026$1.5B +14.8%+17.3%24.2%
ENSGThe Ensign Group, Inc.LTM Jun 2026$621.28M +18.2%+16.4%11.3%
CHEChemed CorporationLTM Jun 2026$431.72M -4.8%+2.4%16.6%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$347.65M +31.1%—13.0%
NHCNational HealthCare CorporationLTM Sep 2026$207.86M +10.1%+46.3%13.1%
ADUSAddus HomeCare CorporationLTM Jun 2026$167.37M +23.6%+22.7%11.3%
PNTGThe Pennant Group, Inc.LTM Mar 2026$60.01M +22.5%+51.2%5.9%
Peer median (excluding ADUS) $389.68M+16.5%+17.3%13.1%

Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue864.5M951.12M1.06B1.15B1.42B
Cost of Revenue595.24M651.38M718.78M779.58M960.66M
Gross Profit269.85M299.74M339.88M375.02M461.87M
Gross Margin31.2%31.5%32.1%32.5%32.5%
Research & Development00000
Selling, General & Admin189.42M216.94M231.68M258.8M306.85M
Operating Expenses203.32M231M248.92M272.33M323.26M
Depreciation & Amortization14.49M14.06M14.13M13.53M16.41M
EBITDA80.7M83.14M106.56M120.62M153.44M
EBITDA Margin9.3%8.7%10.1%10.4%10.8%
Operating Income65.94M68.74M90.96M102.69M138.62M
Operating Margin7.6%7.2%8.6%8.9%9.7%
Interest Income268K341K1.48M4.39M1.59M
Interest Expense5.81M8.91M11.11M7.73M9.58M
Other Income / Expenses(5.54M)(8.57M)(9.63M)(3.34M)(11.17M)
Income Before Tax60.4M60.17M81.33M99.35M127.45M
Pre-Tax Margin7.0%6.3%7.7%8.6%9.0%
Income Tax Expense15.27M14.15M18.81M25.76M31.54M
Net Income45.13M46.03M62.52M73.6M95.91M
Net Margin5.2%4.8%5.9%6.4%6.7%
EPS (Basic)2.872.903.914.335.19
EPS (Diluted)2.812.843.834.235.21
Weighted Avg Shares15.74M16.13M16.23M17.01M18.45M
Weighted Avg Shares (Diluted)16.06M16.18M16.31M17.38M18.45M

Addus HomeCare Corporation

NASDAQ:ADUS

Intrinsic Alpha fair value

Locked

Current Price

$120.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.